CD19/BCMA dual-targeting CAR T-cell therapy

· Institute of Hematology & Blood Diseases Hospital, China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19/BCMA dual-targeting CAR T-cell therapy, covering 2025-09-29 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases [Phase 1]